This conclusion was supported by data generated in in vitro activated mouse CD8+ T cells (Figure 3) and complemented by studies in tumor-bearing mouse models injected with adoptively transferred CD8+ T cells with normal or deficient Rig-I expression (Figures 4 and 5). The gene discussed is CD8A; the disease is neoplasm.